• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓干细胞来源的外泌体通过促进成骨细胞增殖和抑制细胞凋亡来改善骨质疏松症。

Bone marrow stem cells derived exosomes improve osteoporosis by promoting osteoblast proliferation and inhibiting cell apoptosis.

机构信息

Department of Orthopedic, Liuzhou Worker's Hospital, Liuzhou, China.

出版信息

Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1214-1220. doi: 10.26355/eurrev_201902_17014.

DOI:10.26355/eurrev_201902_17014
PMID:30779091
Abstract

OBJECTIVE

The aim of this study was to investigate whether bone marrow stem cells (MSCs) derived exosomes in rats could promote osteoblast proliferation and improve osteoporosis via inhibiting cell apoptosis.

MATERIALS AND METHODS

MSCs in rats were isolated and cultured, followed by the identification of surface antigens via flow cytometry. The differentiation of MSCs was detected by alizarin red staining and oil red staining. After extraction from MSCs by ultracentrifugation, the size distribution of exosomes was detected by tunable resistive pulse sensing (TRPS). Specific antigens in MSCs-derived exosomes were determined by flow cytometry. Furthermore, the proliferation and viability of hFOB1.19 cells treated with MSCs-derived exosomes were detected by cell count kit-8 (CCK-8) assay. The effect of MSCs-derived exosomes on cell apoptosis was evaluated by flow cytometry. Protein expression levels of apoptosis-related genes in hFOB1.19 cells were detected by Western blot.

RESULTS

MSCs differentiated into osteoblasts and lipoblasts under different treatments. Meanwhile, MSCs-derived exosomes exhibited typical elongated morphology after isolation and culture for 1 and 3 days, respectively. Functionally, MSCs-derived exosomes could promote the viability of hFOB1.19 cells, and significantly increase the expression level of GLUT3. In addition, MSCs-derived exosomes remarkably downregulated apoptosis-related genes and decreased apoptosis in hFOB1.19 cells.

CONCLUSIONS

MSCs-derived exosomes could promote osteoblast proliferation via inhibiting cell apoptosis, eventually improving osteoporosis.

摘要

目的

本研究旨在探讨大鼠骨髓间充质干细胞(MSCs)来源的外泌体是否能通过抑制细胞凋亡来促进成骨细胞增殖和改善骨质疏松症。

材料与方法

分离并培养大鼠 MSCs,通过流式细胞术鉴定其表面抗原。通过茜素红染色和油红染色检测 MSCs 的分化情况。通过超速离心从 MSCs 中提取外泌体后,使用可调电阻脉冲感应(TRPS)检测其粒径分布。通过流式细胞术确定 MSCs 来源外泌体中的特异性抗原。进一步通过细胞计数试剂盒-8(CCK-8)检测 hFOB1.19 细胞中经 MSCs 来源外泌体处理后的增殖和活力情况。通过流式细胞术评估 MSCs 来源外泌体对细胞凋亡的影响。通过 Western blot 检测 hFOB1.19 细胞中与凋亡相关的基因的蛋白表达水平。

结果

在不同处理下,MSCs 分化为成骨细胞和脂肪细胞。同时,MSCs 来源的外泌体在分离和培养 1 天和 3 天后分别呈现出典型的细长形态。功能上,MSCs 来源的外泌体可以促进 hFOB1.19 细胞的活力,并显著增加 GLUT3 的表达水平。此外,MSCs 来源的外泌体显著下调了 hFOB1.19 细胞中与凋亡相关的基因,并减少了细胞凋亡。

结论

MSCs 来源的外泌体可以通过抑制细胞凋亡来促进成骨细胞增殖,从而改善骨质疏松症。

相似文献

1
Bone marrow stem cells derived exosomes improve osteoporosis by promoting osteoblast proliferation and inhibiting cell apoptosis.骨髓干细胞来源的外泌体通过促进成骨细胞增殖和抑制细胞凋亡来改善骨质疏松症。
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1214-1220. doi: 10.26355/eurrev_201902_17014.
2
Exosomes derived from bone marrow mesenchymal stem cells improve osteoporosis through promoting osteoblast proliferation via MAPK pathway.骨髓间充质干细胞来源的外泌体通过 MAPK 通路促进成骨细胞增殖来改善骨质疏松症。
Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3962-3970. doi: 10.26355/eurrev_201806_15280.
3
Bone marrow stem cells-derived exosomes extracted from osteoporosis patients inhibit osteogenesis via microRNA-21/SMAD7.骨质疏松症患者骨髓干细胞来源的外泌体通过 microRNA-21/SMAD7 抑制成骨。
Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6221-6229. doi: 10.26355/eurrev_201810_16028.
4
microRNA-935-modified bone marrow mesenchymal stem cells-derived exosomes enhance osteoblast proliferation and differentiation in osteoporotic rats.微小 RNA-935 修饰的骨髓间充质干细胞来源的外泌体增强骨质疏松症大鼠成骨细胞的增殖和分化。
Life Sci. 2021 May 1;272:119204. doi: 10.1016/j.lfs.2021.119204. Epub 2021 Feb 10.
5
Bone Marrow Mesenchymal Stem Cells-Derived Exosomal MicroRNA-150-3p Promotes Osteoblast Proliferation and Differentiation in Osteoporosis.骨髓间充质干细胞衍生的外泌体微小RNA-150-3p促进骨质疏松症中成骨细胞的增殖和分化。
Hum Gene Ther. 2021 Jul;32(13-14):717-729. doi: 10.1089/hum.2020.005. Epub 2021 Jan 22.
6
LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis.骨髓间充质干细胞分泌的外泌体转运的长链非编码RNA MALAT1通过介导微小RNA-34c/SATB2轴减轻骨质疏松症。
Aging (Albany NY). 2019 Oct 26;11(20):8777-8791. doi: 10.18632/aging.102264.
7
Exosomes Secreted by Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Repair Critical-Sized Bone Defects through Enhanced Angiogenesis and Osteogenesis in Osteoporotic Rats.人诱导多能干细胞衍生的间充质干细胞分泌的外泌体通过增强骨质疏松大鼠的血管生成和成骨作用修复临界尺寸骨缺损。
Int J Biol Sci. 2016 May 25;12(7):836-49. doi: 10.7150/ijbs.14809. eCollection 2016.
8
Exosomes promote hFOB1.19 proliferation and differentiation via LINC00520.外泌体通过 LINC00520 促进 hFOB1.19 的增殖和分化。
J Orthop Surg Res. 2023 Jul 29;18(1):546. doi: 10.1186/s13018-023-04021-y.
9
USP36 regulates the proliferation, survival, and differentiation of hFOB1.19 osteoblast.USP36 调控 hFOB1.19 成骨细胞的增殖、存活和分化。
J Orthop Surg Res. 2024 Aug 17;19(1):483. doi: 10.1186/s13018-024-04893-8.
10
Mesenchymal Stem Cells-Derived Exosomes: A Possible Therapeutic Strategy for Osteoporosis.间充质干细胞衍生的外泌体:一种治疗骨质疏松症的可能策略。
Curr Stem Cell Res Ther. 2018;13(5):362-368. doi: 10.2174/1574888X13666180403163456.

引用本文的文献

1
Leveraging Nanoscience and Strategic Delivery for the Expedition of Osteoporosis.利用纳米科学与战略交付推动骨质疏松症研究进展
AAPS PharmSciTech. 2025 May 9;26(5):129. doi: 10.1208/s12249-025-03120-9.
2
The existing evidence for the use of extracellular vesicles in the treatment of osteoporosis: a review.细胞外囊泡用于治疗骨质疏松症的现有证据:一项综述
Int J Surg. 2025 May 1;111(5):3414-3429. doi: 10.1097/JS9.0000000000002339.
3
Involvement of icaritin in the regulation of osteocyte exosomal microRNAs.淫羊藿素参与骨细胞外泌体微小RNA的调控。
J Orthop Surg Res. 2025 Feb 14;20(1):164. doi: 10.1186/s13018-025-05583-9.
4
Intra-articular injection of exosomes derived from different stem cells in animal models of osteoarthritis: a systematic review and meta- analysis.骨关节炎动物模型中关节内注射不同干细胞来源的外泌体:一项系统评价和荟萃分析。
J Orthop Surg Res. 2024 Dec 18;19(1):834. doi: 10.1186/s13018-024-05227-4.
5
The Potential of Exosomes for Osteoporosis Treatment: A Review.外泌体在骨质疏松治疗中的潜力:综述。
Drug Des Devel Ther. 2024 Mar 28;18:979-989. doi: 10.2147/DDDT.S437596. eCollection 2024.
6
Cellular and Molecular Connections Between Bone Fracture Healing and Exosomes.骨愈合与外泌体的细胞和分子联系。
Physiol Res. 2023 Nov 28;72(5):565-574. doi: 10.33549/physiolres.935143.
7
Extracellular Vesicles in Bone Remodeling and Osteoporosis.细胞外囊泡在骨重建和骨质疏松症中的作用
Adv Exp Med Biol. 2023;1418:155-168. doi: 10.1007/978-981-99-1443-2_11.
8
Bone regeneration in inflammation with aging and cell-based immunomodulatory therapy.衰老炎症状态下的骨再生与基于细胞的免疫调节治疗
Inflamm Regen. 2023 May 25;43(1):29. doi: 10.1186/s41232-023-00279-1.
9
Osteoporosis treatment using stem cell-derived exosomes: a systematic review and meta-analysis of preclinical studies.干细胞衍生外泌体治疗骨质疏松症的系统评价和荟萃分析:临床前研究。
Stem Cell Res Ther. 2023 Apr 11;14(1):72. doi: 10.1186/s13287-023-03317-4.
10
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier.间充质干细胞(MSCs)及其衍生外泌体在骨与关节相关肌肉骨骼疾病中的新兴作用:一个新的前沿领域。
Eur J Med Res. 2023 Feb 20;28(1):86. doi: 10.1186/s40001-023-01034-5.